blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1909783

EP1909783 - ILLUDIN ANALOGS USEFUL AS ANTICANCER AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.08.2012
Database last updated on 26.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU
published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2008/16]For all designated states
The Regents of the University of California
Office of Technology Transfer 1111 Franklin Street, 12th Floor
Oakland CA 94607-5200 / US
Inventor(s)01 / MCMORRIS, Trevor C.
8911 Nottingham Place
La Jolla, 92037 California / US
02 / KELNER, Michael J.
5545 Coral Reef Avenue
La Jolla, 92037 California / US
 [2008/16]
Representative(s)Lucas, Phillip Brian, et al
Lucas & Co.
135 Westhall Road
Warlingham, Surrey CR6 9HJ / GB
[N/P]
Former [2008/16]Lucas, Phillip Brian, et al
Lucas & Co. 135 Westhall Road
Warlingham, Surrey CR6 9HJ / GB
Application number, filing date06800754.103.08.2006
[2008/16]
WO2006US30439
Priority number, dateUS20050705017P03.08.2005         Original published format: US 705017 P
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007019308
Date:15.02.2007
Language:EN
[2007/07]
Type: A2 Application without search report 
No.:EP1909783
Date:16.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application.
[2008/16]
Type: B1 Patent specification 
No.:EP1909783
Date:12.10.2011
Language:EN
[2011/41]
Search report(s)International search report - published on:US12.07.2007
(Supplementary) European search report - dispatched on:EP05.07.2010
ClassificationIPC:A61K31/27, A61K31/17, A61K31/13, C07C271/18, C07C271/22, C07C239/14, C07C239/18, C07C275/22, C07C275/24, C07C335/10
[2008/16]
CPC:
C07C275/26 (EP,US); A61P35/00 (EP); C07C2603/97 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/16]
TitleGerman:ILLUDIN-ANALOGA ALS KREBSMITTEL[2008/16]
English:ILLUDIN ANALOGS USEFUL AS ANTICANCER AGENTS[2008/16]
French:ANALOGUES D'ILLUDINE UTILES EN TANT QU'AGENTS ANTICANCEREUX[2008/16]
Entry into regional phase31.01.2008National basic fee paid 
31.01.2008Search fee paid 
31.01.2008Designation fee(s) paid 
31.01.2008Examination fee paid 
Examination procedure31.01.2008Examination requested  [2008/16]
13.01.2011Amendment by applicant (claims and/or description)
04.04.2011Communication of intention to grant the patent
07.07.2011Fee for grant paid
07.07.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.04.2011
Opposition(s)13.07.2012No opposition filed within time limit [2012/38]
Fees paidRenewal fee
25.08.2008Renewal fee patent year 03
25.08.2009Renewal fee patent year 04
24.11.2010Renewal fee patent year 05
25.08.2011Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.201005   M06   Fee paid on   24.11.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.08.2006
AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
TR12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
[2014/34]
Former [2014/21]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
TR12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/29]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/22]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/07]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/37]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/36]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/35]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
SE12.10.2011
SI12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/34]BE12.10.2011
CY12.10.2011
CZ12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/28]BE12.10.2011
CY12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/24]BE12.10.2011
LT12.10.2011
LV12.10.2011
NL12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/23]BE12.10.2011
LT12.10.2011
NL12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/21]BE12.10.2011
LT12.10.2011
IS12.02.2012
Former [2012/20]LT12.10.2011
Documents cited:Search[A]WO9418151  (UNIV CALIFORNIA [US]) [A] 1-3,15-36 * claim 1 *;
 [A]WO9942429  (UNIV CALIFORNIA [US], et al) [A] 1-3,15-36 * claim 1 *;
 [A]US2002086815  (MCMORRIS TREVOR C [US], et al) [A] 1-3,15-36 * claim 1 *;
 [A]US2004167100  (MCMORRIS TREVOR C [US], et al) [A] 1-3,15-36 * claim 1 *;
 [A]US6855696  (MCMORRIS TREVOR C [US], et al) [A] 1-3,15-36* claim 1 *
International search[A]US6235789  (OHKAWA SHIGENORI [JP], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.